SEC Form 4 · accession 0000059478-18-000286
ELI LILLY & Co · LLY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anne E. White
Officer — SVP & Pres-Lilly Oncology
Period of report
Dec 2, 2018
Accepted (ET)
Dec 4, 2018 · 3:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000059478
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 2, 2018 | M | 7,500 | $0.00 | A | 17,103 | D | |
| Common Stock | Dec 2, 2018 | F | 3,306 | $118.64 | D | 13,797 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1 | — | Dec 2, 2018 | M | 7,500 | D | Dec 2, 2018 | Dec 2, 2018 | Common Stock | 7,500 | 0 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.